Non-small Cell Lung Cancer and Quality of Life (SILKE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Maria Silvoniemi, University of Turku
ClinicalTrials.gov Identifier:
NCT00818402
First received: January 5, 2009
Last updated: May 28, 2015
Last verified: May 2015
  Purpose
The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Condition
Non Small Cell Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control

Resource links provided by NLM:


Further study details as provided by University of Turku:

Biospecimen Retention:   Samples With DNA
whole blood

Enrollment: 130
Study Start Date: August 2008
Study Completion Date: February 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Non-small cell lung cancer patients

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The patients treated in the clinic of respiratory medicine in Turku, Finland
Criteria

Inclusion Criteria:

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

Exclusion Criteria:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Maria Silvoniemi, MD, University of Turku
ClinicalTrials.gov Identifier: NCT00818402     History of Changes
Other Study ID Numbers: SILKE-ETMK:47/180/2008 
Study First Received: January 5, 2009
Last Updated: May 28, 2015
Health Authority: Finland: Ethics Committee

Keywords provided by University of Turku:
Quality of life
symptoms

Additional relevant MeSH terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms

ClinicalTrials.gov processed this record on August 23, 2016